Great Lakes Advisors LLC Lowers Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Great Lakes Advisors LLC lessened its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 12.7% during the 4th quarter, Holdings Channel reports. The firm owned 679 shares of the biotechnology company’s stock after selling 99 shares during the period. Great Lakes Advisors LLC’s holdings in Axon Enterprise were worth $404,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in AXON. Apollon Wealth Management LLC grew its holdings in Axon Enterprise by 11.3% during the 3rd quarter. Apollon Wealth Management LLC now owns 1,304 shares of the biotechnology company’s stock valued at $521,000 after buying an additional 132 shares in the last quarter. GSA Capital Partners LLP increased its holdings in Axon Enterprise by 61.2% in the 3rd quarter. GSA Capital Partners LLP now owns 1,736 shares of the biotechnology company’s stock valued at $694,000 after acquiring an additional 659 shares during the last quarter. KBC Group NV lifted its stake in Axon Enterprise by 80.6% in the 3rd quarter. KBC Group NV now owns 12,397 shares of the biotechnology company’s stock worth $4,954,000 after purchasing an additional 5,532 shares in the last quarter. OneDigital Investment Advisors LLC boosted its holdings in shares of Axon Enterprise by 35.8% during the 3rd quarter. OneDigital Investment Advisors LLC now owns 2,053 shares of the biotechnology company’s stock valued at $820,000 after purchasing an additional 541 shares during the last quarter. Finally, CIBC Asset Management Inc grew its position in shares of Axon Enterprise by 9.2% during the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after purchasing an additional 895 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Stock Up 4.1 %

Shares of NASDAQ:AXON opened at $556.26 on Monday. The firm has a market capitalization of $42.62 billion, a PE ratio of 143.74, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The business has a 50 day simple moving average of $593.42 and a two-hundred day simple moving average of $536.68. Axon Enterprise, Inc. has a 1 year low of $273.52 and a 1 year high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Insider Buying and Selling

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, President Joshua Isner sold 1,291 shares of the business’s stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total transaction of $829,377.13. Following the sale, the president now directly owns 181,892 shares of the company’s stock, valued at $116,852,877.56. This represents a 0.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 4,146 shares of company stock valued at $2,623,157. Insiders own 6.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on AXON shares. Barclays reissued a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Needham & Company LLC reissued a “buy” rating and issued a $600.00 target price on shares of Axon Enterprise in a report on Wednesday, February 26th. TD Cowen initiated coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. The Goldman Sachs Group lifted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Finally, Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $604.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.